Aug 3, 2021
August 03, 2021 07:00 AM Eastern Daylight Time WOBURN, Mass.–(BUSINESS WIRE)–ReForm Biologics, Inc., a company developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience, today announced that John...
Jul 26, 2021
Absci IPO From a basement lab to Times Square! It was a thrill to ring the @Nasdaq closing bell today and light up NYC! #absci $ABSI...
Jul 23, 2021
Biotech CEOs tend to have advanced degrees and multiple academic credentials under their belt. But Sean McClain started Absci as a freshly minted grad from the University of Arizona at age 22, living with his parents and working out of a basement lab. Fast forward a...
Jul 21, 2021
MIT spinout Inkbit has raised $30 million in a Series B funding round led by venture capital firm Phoenix Venture Partners (PVP). The company intends to use the funds to accelerate the production of its recently launched highly automated 3D printing Inkbit...
Jul 2, 2021
Sean McClain started Absci as a 22-year-old college graduate in a small basement lab — or as he called it, a “dungeon lab” — in downtown Portland, OR. Ten years later, he’s taking the company public. Absci filed S-1 papers on Wednesday, penciling in a $100 million...
Jul 1, 2021
VANCOUVER, Wash., June 30, 2021 /PRNewswire/ — Absci Corporation (“Absci”), the synthetic biology company unlocking the potential of proteins as next-generation therapeutics, announced today that it has filed a registration statement on Form S-1 with the U.S....
